申请人:Bayer Aktiengesellschaft
公开号:US05874462A1
公开(公告)日:1999-02-23
The invention relates to the use of substituted 6-amino-4H-pyrans for the production of medicaments for the treatment of cerebral disorders, in particular of degenerative disorders such as dementia, and also for treatment of depressions and psychoses. New active compounds are prepared by reaction of the corresponding ylidene compounds with malononitrile.
该发明涉及使用取代的6-氨基-4H-吡喃烷衍生物制备用于治疗脑部疾病的药物,特别是退行性疾病,如痴呆症,以及治疗抑郁症和精神病。通过将相应的叶立德化合物与马隆酰亚胺反应制备出新的活性化合物。